Tag Archives: U.S.

Amid vaping crisis, U.S. to issue new advice for doctors focused on lung infections

CHICAGO (Reuters) – U.S. health officials are preparing to release new guidance for doctors stressing the need to ask every patient with an apparent respiratory infection about their vaping history. Jeffrey Manzanares, 33, lies in the intensive care unit of the University of Utah Hospital while being treated for vaping injury and other lung infections… Read More »

Can psychedelics treat anorexia, depression? U.S. scientists get millions to find out

Since childhood, Rachael Petersen had lived with an unexplainable sense of grief that no drug or talk therapy could entirely ease. So in 2017 she volunteered for a small clinical trial at Johns Hopkins University that was testing psilocybin, the active ingredient in magic mushrooms, for chronic depression. “I was so depressed,” Petersen, 29, said… Read More »

Part 2: The U.S. has fantastic health care, the problem is….

MISSED PART 1 OF THIS EXECUTIVE INTERVIEW SERIES? READ NOW to learn about Dr. Wyatt Decker’s perspectives on the state and challenges of the health care industry, where it’s smart for leaders to focus, what change means for different stakeholders across health care and lessons learned from a physician executive. Imagine this scenario: there are… Read More »

Pfizer’s keys to juggling 8 U.S. launches? Organization, accountability, clear goals

Think you’re busy? Take a look at Pfizer’s commercial team for oncology, which is currently launching four new drugs, three new indications for older drugs, and a biosimilar. And that’s just in the U.S. It’s taken some serious internal organizing on Pfizer’s part, but so far managing the multiple rollouts has been “done very well,”… Read More »